Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-25 @ 3:27 AM
NCT ID:
NCT00145405
Eligibility Criteria:
Inclusion Criteria:
* All the patients which receive octreotide LAR can be included;
* New diagnosed patients with clinical and biochemical acromegaly , if medicine therapy is indicated;
* As long as they do not fit in the exclusion criteria.
Exclusion Criteria:
* Which had not given their consent after they received standard information about the study;
* Current malign disease;
* Somatostatin analogues intolerance;
* Elevation of lever enzymes;
* Pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
22 Years
Maximum Age:
72 Years
Study:
NCT00145405
Study Brief:
Protocol Section:
NCT00145405